GTHX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Notice: This stock is marked as potentially delisted. It may not be actively trading.

Insider Ownership Percentage: 6.11%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $54,999.53

G1 Therapeutics Insider Trading History Chart

G1 Therapeutics Share Price & Price History

^$7.15

+0.30 (1.20%)

As of 09/18/2024 01:00 AM ET

G1 Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/5/2024	Andrew Perry	Insider	Sell	1,337	$2.51	$3,355.87	112,614
7/5/2024	John E (Jack) Bailey, Jr.	CEO	Sell	7,662	$2.51	$19,231.62	549,674
7/5/2024	John W V Umstead	CFO	Sell	527	$2.51	$1,322.77	187,718
7/5/2024	Terry L Murdock	COO	Sell	2,475	$2.51	$6,212.25	128,012
5/23/2024	Monica R Thomas	Insider	Sell	5,826	$4.27	$24,877.02	109,825
3/18/2024	John W V Umstead	CFO	Sell	6,547	$3.02	$19,771.94	123,896
2/12/2024	Rajesh Malik	Insider	Sell	28,600	$4.62	$132,132.00	169,938
1/4/2024	John W V Umstead	CFO	Sell	111	$2.94	$326.34	130,443
1/4/2024	Terry L Murdock	COO	Sell	721	$2.94	$2,119.74	103,638
1/3/2024	Rajesh Malik	Insider	Sell	3,019	$3.12	$9,419.28	170,659
1/2/2024	John E (Jack) Bailey, Jr.	CEO	Sell	32,983	$3.27	$107,854.41	400,580
12/11/2023	Rajesh Malik	Insider	Sell	33,839	$3.41	$115,390.99	136,378
7/5/2023	Andrew Perry	Insider	Sell	355	$2.45	$869.75	55,945
7/5/2023	John E (Jack) Bailey, Jr.	CEO	Sell	2,719	$2.45	$6,661.55	433,563
7/5/2023	Terry L Murdock	COO	Sell	1,361	$2.45	$3,334.45	70,078
1/5/2023	Terry L Murdock	COO	Sell	729	$5.41	$3,943.89	36,439
1/4/2023	Andrew Perry	Insider	Sell	820	$5.58	$4,575.60	21,300
1/4/2023	Jennifer K Moses	CFO	Sell	1,639	$5.58	$9,145.62	58,549
1/3/2023	John E (Jack) Bailey, Jr.	CEO	Sell	32,019	$5.85	$187,311.15	281,889
10/18/2022	Mark A. Velleca	Director	Sell	15,000	$11.70	$175,500.00	116,000
9/20/2022	Mark A. Velleca	Director	Sell	20,000	$13.50	$270,000.00	116,000
9/13/2022	Rajesh Malik	Insider	Sell	18,000	$15.71	$282,780.00	73,207
8/16/2022	Mark A. Velleca	Director	Sell	80,000	$12.64	$1,011,200.00	116,000
7/5/2022	Terry L Murdock	COO	Sell	648	$5.17	$3,350.16	20,907

See Full Table

SEC Filings (Institutional Ownership Changes) for G1 Therapeutics (NASDAQ:GTHX)

24.21% of G1 Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

G1 Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/15/2024	Mackenzie Financial Corp	12,338	$28K	0.0%	N/A	0.024%
8/12/2024	XTX Topco Ltd	21,020	$48K	0.0%	+104.0%	0.040%
8/12/2024	Marathon Trading Investment Management LLC	20,220	$46K	0.0%	N/A	0.039%
8/9/2024	Renaissance Technologies LLC	1,245,180	$2.84M	0.0%	+37.8%	2.382%
8/9/2024	Dimensional Fund Advisors LP	74,826	$0.17M	0.0%	-3.5%	0.143%
8/6/2024	Acadian Asset Management LLC	928,205	$2.11M	0.0%	+114.0%	1.775%
8/6/2024	Los Angeles Capital Management LLC	20,986	$48K	0.0%	N/A	0.040%
8/1/2024	Rhumbline Advisers	50,632	$0.12M	0.0%	+5,136.0%	0.097%
7/29/2024	Panagora Asset Management Inc.	177,051	$0.40M	0.0%	N/A	0.339%
7/26/2024	Bank of New York Mellon Corp	133,230	$0.30M	0.0%	N/A	0.255%
7/19/2024	Raymond James & Associates	797,677	$1.82M	0.0%	-0.6%	1.526%
7/12/2024	SG Americas Securities LLC	47,124	$0.11M	0.0%	+248.1%	0.090%
5/16/2024	Jacobs Levy Equity Management Inc.	377,858	$1.63M	0.0%	+20.7%	0.723%
5/10/2024	Acadian Asset Management LLC	433,709	$1.87M	0.0%	+643.2%	0.830%
5/10/2024	Vanguard Group Inc.	2,081,573	$8.99M	0.0%	+5.0%	3.982%
5/7/2024	SG Americas Securities LLC	13,536	$58K	0.0%	N/A	0.026%
4/19/2024	Denali Advisors LLC	86,100	$0.37M	0.1%	-29.3%	0.165%
2/15/2024	Birchview Capital LP	80,000	$0.24M	0.2%	-33.3%	0.154%
2/13/2024	FinTrust Capital Advisors LLC	100,780	$0.31M	0.1%	+154,946.2%	0.194%
2/12/2024	Capstone Investment Advisors LLC	25,000	$76K	0.0%	N/A	0.048%
2/8/2024	Level Four Advisory Services LLC	178,600	$0.55M	0.0%	-2.6%	0.345%
2/8/2024	Financial Advocates Investment Management	12,950	$39K	0.0%	N/A	0.025%
2/7/2024	Jump Financial LLC	34,400	$0.11M	0.0%	N/A	0.066%
2/5/2024	Choreo LLC	35,234	$0.11M	0.0%	N/A	0.068%
1/31/2024	abrdn plc	423,869	$1.29M	0.0%	N/A	0.818%
1/19/2024	Denali Advisors LLC	121,800	$0.37M	0.1%	-18.1%	0.235%
1/16/2024	Raymond James Financial Services Advisors Inc.	33,719	$0.10M	0.0%	-22.4%	0.065%
1/16/2024	Raymond James & Associates	565,555	$1.73M	0.0%	-38.9%	1.091%
1/10/2024	Creative Financial Designs Inc. ADV	35,280	$0.11M	0.0%	+98.1%	0.068%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	204,200	$0.29M	0.0%	+68.3%	0.394%
11/13/2023	Algert Global LLC	68,100	$98K	0.0%	N/A	0.131%
11/13/2023	Acadian Asset Management LLC	131,585	$0.19M	0.0%	N/A	0.254%
11/6/2023	Curi Wealth Management LLC	70,742	$0.10M	0.0%	+17.8%	0.137%
10/24/2023	Raymond James & Associates	925,776	$1.33M	0.0%	+16.9%	1.789%
10/20/2023	Denali Advisors LLC	148,800	$0.21M	0.1%	+121.8%	0.288%
10/10/2023	Franklin Street Advisors Inc. NC	83,400	$0.12M	0.0%	+142.4%	0.161%
8/14/2023	Graham Capital Management L.P.	55,805	$0.14M	0.0%	N/A	0.108%
8/11/2023	Financial Engines Advisors L.L.C.	15,107	$38K	0.0%	N/A	0.029%
8/8/2023	Fisher Asset Management LLC	2,543,006	$6.33M	0.0%	-6.7%	4.914%
7/31/2023	Curi Wealth Management LLC	60,042	$0.15M	0.0%	-25.9%	0.116%
7/26/2023	Creative Financial Designs Inc. ADV	17,505	$44K	0.0%	+60.6%	0.034%
7/25/2023	Raymond James & Associates	792,114	$1.97M	0.0%	+6.0%	1.533%
7/24/2023	Allspring Global Investments Holdings LLC	31,443	$78K	0.0%	N/A	0.061%
7/18/2023	Denali Advisors LLC	67,100	$0.17M	0.1%	N/A	0.130%
7/18/2023	Allspring Global Investments Holdings LLC	31,443	$78K	0.0%	N/A	0.061%
6/5/2023	Level Four Advisory Services LLC	86,500	$0.23M	0.0%	N/A	0.167%
5/15/2023	XTX Topco Ltd	294,292	$0.79M	0.2%	+187.7%	0.570%
5/10/2023	Landscape Capital Management L.L.C.	38,569	$0.10M	0.0%	-31.3%	0.075%
5/10/2023	Connor Clark & Lunn Investment Management Ltd.	16,513	$44K	0.0%	N/A	0.032%
5/8/2023	Zurcher Kantonalbank Zurich Cantonalbank	12,135	$33K	0.0%	N/A	0.023%
5/1/2023	Fisher Asset Management LLC	2,724,710	$7.30M	0.0%	-3.0%	5.274%
4/28/2023	SG Americas Securities LLC	39,214	$0.11M	0.0%	-16.6%	0.076%
4/14/2023	Raymond James & Associates	747,411	$2M	0.0%	+49.8%	1.447%
4/12/2023	Franklin Street Advisors Inc. NC	33,160	$89K	0.0%	+43.2%	0.064%
2/14/2023	683 Capital Management LLC	27,292	$0.15M	0.0%	N/A	0.064%
2/14/2023	Alpine Global Management LLC	24,085	$0.13M	0.0%	N/A	0.056%
2/10/2023	HRT Financial LP	107,275	$0.58M	0.0%	N/A	0.250%
2/9/2023	Landscape Capital Management L.L.C.	56,117	$0.31M	0.0%	N/A	0.131%
2/8/2023	Raymond James Financial Services Advisors Inc.	44,148	$0.24M	0.0%	-15.1%	0.103%
2/8/2023	Raymond James & Associates	498,903	$2.71M	0.0%	+4.0%	1.163%
2/8/2023	Swiss National Bank	103,500	$0.56M	0.0%	N/A	0.241%
2/8/2023	Arizona State Retirement System	12,099	$66K	0.0%	N/A	0.028%
2/7/2023	Fox Run Management L.L.C.	23,542	$0.13M	0.1%	N/A	0.055%
2/3/2023	Fisher Asset Management LLC	2,809,444	$15.26M	0.0%	-4.3%	6.547%
2/3/2023	Curi Wealth Management LLC	81,009	$0.44M	0.1%	+37.9%	0.189%
2/2/2023	SG Americas Securities LLC	47,047	$0.26M	0.0%	+22.6%	0.110%
2/1/2023	Bank of Montreal Can	109,339	$0.60M	0.0%	N/A	0.255%
11/16/2022	Alpha DNA Investment Management LLC	42,477	$0.53M	0.4%	N/A	0.099%
11/15/2022	Marshall Wace LLP	632,178	$7.90M	0.0%	+32.6%	1.473%
11/14/2022	Tudor Investment Corp Et Al	84,119	$1.05M	0.0%	+87.1%	0.196%
11/14/2022	Cubist Systematic Strategies LLC	444,841	$5.56M	0.0%	+72.5%	1.037%
11/14/2022	PDT Partners LLC	45,605	$0.57M	0.1%	-42.7%	0.106%
11/10/2022	Connor Clark & Lunn Investment Management Ltd.	90,139	$1.13M	0.0%	+127.3%	0.210%
11/10/2022	ExodusPoint Capital Management LP	78,938	$0.99M	0.0%	+613.2%	0.184%
11/10/2022	Tower Research Capital LLC TRC	17,404	$0.22M	0.0%	+549.4%	0.041%
11/9/2022	Magnus Financial Group LLC	25,000	$0.31M	0.1%	N/A	0.058%
11/8/2022	Fisher Asset Management LLC	2,935,332	$36.66M	0.0%	+27.2%	6.841%
11/8/2022	Curi Wealth Management LLC	58,737	$0.73M	0.1%	-30.7%	0.137%
11/7/2022	Virtu Financial LLC	34,923	$0.44M	0.0%	+246.4%	0.081%
11/7/2022	Jump Financial LLC	39,500	$0.49M	0.0%	-3.8%	0.092%
11/3/2022	Barclays PLC	113,631	$1.42M	0.0%	N/A	0.266%
11/1/2022	Creative Financial Designs Inc. ADV	12,000	$0.15M	0.0%	N/A	0.028%
10/27/2022	US Bancorp DE	2,736	$34K	0.0%	N/A	0.006%
10/25/2022	Raymond James & Associates	479,635	$5.99M	0.0%	+9.5%	1.122%
10/25/2022	AE Wealth Management LLC	44,005	$0.55M	0.0%	N/A	0.103%
9/16/2022	Federated Hermes Inc.	179,472	$0.89M	0.0%	+353.2%	0.420%
8/16/2022	Woodline Partners LP	1,797,182	$8.88M	0.1%	N/A	4.204%
8/15/2022	Laurion Capital Management LP	12,656	$63K	0.0%	N/A	0.030%
8/13/2022	Needham Investment Management LLC	134,000	$0.66M	0.1%	-16.3%	0.313%
8/12/2022	Ensign Peak Advisors Inc	25,220	$0.13M	0.0%	+225.8%	0.059%
8/11/2022	Trexquant Investment LP	18,171	$90K	0.0%	N/A	0.043%
8/11/2022	JPMorgan Chase & Co.	2,129,449	$10.52M	0.0%	+1.5%	4.981%
8/8/2022	Bay Colony Advisory Group Inc d b a Bay Colony Advisors	14,195	$0.12M	0.0%	N/A	0.033%
8/8/2022	Curi Wealth Management LLC	84,737	$0.42M	0.1%	N/A	0.198%
8/8/2022	Y Intercept Hong Kong Ltd	17,100	$84K	0.0%	N/A	0.040%
8/5/2022	Connor Clark & Lunn Investment Management Ltd.	39,658	$0.20M	0.0%	N/A	0.093%
6/30/2022	Amalgamated Bank	5,782	$44K	0.0%	N/A	0.014%
5/16/2022	Pinz Capital Management LP	186,515	$1.42M	0.9%	N/A	0.437%
5/11/2022	JPMorgan Chase & Co.	2,097,753	$15.94M	0.0%	-2.1%	4.912%
5/9/2022	Qube Research & Technologies Ltd	16,622	$0.13M	0.0%	-47.1%	0.039%

Data available starting January 2016

See Full Table

G1 Therapeutics, Inc., a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer in the United States. The company offers COSELA, which helps to decrease incidence of chemotherapy-induced myelosuppression in adult patients treated with a platinum/etoposide-containing regimen or topotecan-containing regimen for extensive stage small cell lung cancer. It is also developing Trilaciclib that is in Phase 3 clinical trial for 1L metastatic triple negative breast cancer (mTNBC); and Phase 2 clinical trial as an antibody-drug conjugate combination trial in mTNBC, as well as completed Phase 2 clinical trial for Neoadjuvant TNBC and 1L Bladder cancer. The company has a license agreement with Genor Biopharma Co. Inc. for the development and commercialization of lerociclib using an oral dosage form to treat various indication in humans; Incyclix for the development and commercialization of a CDK2 inhibitor for all human and veterinary uses; and Simcere Pharmaceutical Co., Ltd for the development and commercialization of trilaciclib in all indications. G1 Therapeutics, Inc. was incorporated in 2008 and is headquartered in Research Triangle Park, North Carolina.

Today's Range

Now: $7.15

$7.15

50 Day Range

MA: $7.13

$7.08

$7.15

52 Week Range

Now: $7.15

$1.08

$7.19

Volume

N/A

Average Volume

1,701,154 shs

Market Capitalization

$373.81 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.66

Who are the company insiders with the largest holdings of G1 Therapeutics?: G1 Therapeutics' top insider shareholders include:
John E (Jack) Jr Bailey (CEO)
John W V Umstead (CFO)
Rajesh Malik (Insider)
Terry L Murdock (COO)
Andrew Perry (Insider)
Monica R Thomas (Insider)
Learn More about top insider investors at G1 Therapeutics.